Nanoviricides Inc is a nano-biopharmaceutical company which is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through an in-licensing strategy.
Earnings
see more| Q2 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.220 | ||||||
| REV | 0 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| NNVC | NanoViricides, Inc. Common Stock | -7.17% | 44.2M |
NanoViricides, Inc. Common Stock Company Questions & Answers
Q
How do I buy NanoViricides, Inc. Common Stock (NNVC) stock?
A
You can purchase shares of NanoViricides, Inc. Common Stock (AMEX: NNVC) through any online brokerage.
Q
Who are NanoViricides, Inc. Common Stock's (NNVC) main competitors?
A
There are no as such competitors for NanoViricides, Inc. Common Stock.
Q
What is the target price for NanoViricides, Inc. Common Stock?
A
There is no analysis for NanoViricides, Inc. Common Stock
Q
How much is NanoViricides, Inc. Common Stock (NNVC) stock ?
A
The stock price for NanoViricides, Inc. Common Stock (AMEX: NNVC) is $4.14 last updated Thu Feb 25 2021 20:59:44 GMT+0000 (Coordinated Universal Time).
Q
When is the next NanoViricides, Inc. Common Stock (NNVC) dividend?
A
There are no upcoming dividends for NanoViricides, Inc. Common Stock.
Q
When is NanoViricides, Inc. Common Stock (AMEX:NNVC) reporting earnings?
A
NanoViricides, Inc. Common Stock’s Q2 earnings are confirmed after-market from now on February 16, 2021.
Q
When is the upcoming split for NNVC?
A
There is no upcoming split for NanoViricides, Inc. Common Stock.